FAS Wealth Partners’s Boston Scientific BSX Stock Holding History

FAS Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311K	Hold	7,277	–	–	0.02%	291
2026 Q1	$457K	Buy	7,277 +11	+0.2%	+$880	0.03%	240
2025 Q4	$693K	Sell	7,266 -9	-0.1%	-$882	0.04%	204
2025 Q3	$710K	Sell	7,275 -6	-0.1%	-$621	0.05%	194
2025 Q2	$782K	Buy	7,281 +15	+0.2%	+$1.52K	0.06%	180
2025 Q1	$733K	Hold	7,266	–	–	0.06%	172
2024 Q4	$649K	Sell	7,266 -14,235	-66%	-$1.25M	0.05%	183
2024 Q3	$1.8M	Buy	21,501 +14,235	+196%	+$1.12M	0.14%	122
2024 Q2	$560K	Hold	7,266	–	–	0.05%	194
2024 Q1	$498K	Buy	7,266 +137	+2%	+$8.81K	0.04%	207
2023 Q4	$412K	Hold	7,129	–	–	0.04%	214
2023 Q3	$376K	Buy	7,129 +285	+4%	+$14.9K	0.04%	213
2023 Q2	$370K	Buy	6,844 +135	+2%	+$7.05K	0.05%	194
2023 Q1	$336K	Hold	6,709	–	–	0.04%	224
2022 Q4	$310K	Sell	6,709 -96	-1%	-$4.16K	0.04%	238
2022 Q3	$264K	Sell	6,805 -5,807	-46%	-$233K	0.03%	241
2022 Q2	$470K	Buy	+12,612	New	+$513K	0.05%	189

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FAS Wealth Partners's BSX Position: Q2 2026 in Review

FAS Wealth Partners held its Boston Scientific (BSX) position steady in Q2 2026 at 7,277 shares worth $311K. The position accounts for 0.02% of the portfolio, ranked #291.

FAS Wealth Partners first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.8M in Q3 2024. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

FAS Wealth Partners held 7,277 shares of Boston Scientific worth $311K as of Q2 2026.
FAS Wealth Partners left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.02% of FAS Wealth Partners's portfolio in Q2 2026, its #291 holding.
FAS Wealth Partners first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
FAS Wealth Partners's Boston Scientific position peaked at $1.8M in Q3 2024.
1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.